Vanguard Global Advisers
CRVO icon

Vanguard Global Advisers’s CervoMed CRVO Stock Holding History

Vanguard Global Advisers’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.05K Hold
2,597
– – ﹤0.01% 3511
2026
Q1 		$10.2K Buy
+2,597
New +$13.6K ﹤0.01% 3473

Other funds holding CRVO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

Vanguard Global Advisers's CRVO Position: Q2 2026 in Review

Vanguard Global Advisers held its CervoMed (CRVO) position steady in Q2 2026 at 2,597 shares worth $8.05K. The position accounts for ﹤0.01% of the portfolio, ranked #3511.

Vanguard Global Advisers first reported a position in CRVO in Q1 2026 and has held it in 2 quarters since. The position peaked at $10.2K in Q1 2026. 36 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • Vanguard Global Advisers held 2,597 shares of CervoMed worth $8.05K as of Q2 2026.
  • Vanguard Global Advisers left its CervoMed share count unchanged in Q2 2026.
  • CervoMed made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3511 holding.
  • Vanguard Global Advisers first reported a position in CervoMed in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's CervoMed position peaked at $10.2K in Q1 2026.
  • 36 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.